Literature DB >> 22499726

Estimation of the mean frequency function for recurrent events when ascertainment of events is delayed.

T Charles Casper1, Thomas D Cook.   

Abstract

In many large clinical trials there are delays between the time at which events occur and the time at which they are reported. Estimators of the mean frequency function for recurrent events that are currently used are inconsistent in these circumstances. We propose two new estimators to be used when events are reported with delay. One method is a basic inverse probability of censoring weighting approach, while the other explicitly estimates the distribution of the reporting delays. The asymptotic properties of these estimators are discussed and variance estimators are given. We examine the results of simulations comparing the new estimators to each other and to existing estimators that do not properly account for the delays. We also calculate some of these quantities using data from TNT, a clinical trial in which there were delays and events of interest were recurrent.

Entities:  

Mesh:

Year:  2012        PMID: 22499726      PMCID: PMC5166580          DOI: 10.1515/1557-4679.1303

Source DB:  PubMed          Journal:  Int J Biostat        ISSN: 1557-4679            Impact factor:   0.968


  5 in total

1.  Nonparametric survival estimation when death is reported with delay.

Authors:  A E Hubbard; M J Van der Laan; W Enanoria; J M Colford
Journal:  Lifetime Data Anal       Date:  2000-09       Impact factor: 1.588

2.  Nonparametric analysis of recurrent events and death.

Authors:  D Ghosh; D Y Lin
Journal:  Biometrics       Date:  2000-06       Impact factor: 2.571

3.  Use of the Wei-Lin-Weissfeld method for the analysis of a recurring and a terminating event.

Authors:  Q H Li; S W Lagakos
Journal:  Stat Med       Date:  1997-04-30       Impact factor: 2.373

4.  Marginal analysis of recurrent events and a terminating event.

Authors:  R J Cook; J F Lawless
Journal:  Stat Med       Date:  1997-04-30       Impact factor: 2.373

5.  Intensive lipid lowering with atorvastatin in patients with stable coronary disease.

Authors:  John C LaRosa; Scott M Grundy; David D Waters; Charles Shear; Philip Barter; Jean-Charles Fruchart; Antonio M Gotto; Heiner Greten; John J P Kastelein; James Shepherd; Nanette K Wenger
Journal:  N Engl J Med       Date:  2005-03-08       Impact factor: 91.245

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.